《ASCO进展胰腺癌课件》由会员分享，可在线阅读，更多相关《ASCO进展胰腺癌课件（26页珍藏版）》请在金锄头文库上搜索。
1、 ARandomizedPhaseIItrialofAdjuvantChemotherapywithS-1vsS-1andGemcitabine(GS)vsGemcitabinealone(GEMI)inPatientswithresectedPancreaticCancer(CAP-002study)EE江育江2才主要线点2年DFS。GEM组:GEM1000mg/m2,d1,8,15,q4wX12胺y浩s5沥uH租禾2门F3SamlneiyGmoupn。骆-GEM3025184一83228121002一G8引344313159枢Surivaltimetrontt46999“214688129
2、262弛.1326279a量E53&s呈=E=5园Surivalime(montisHdeyuYoshtomistal2013ASC0abstact4055GLIQ20EIJ)S-1组(N=31)1)3J)21(70.0%)028(90.3%)无治疗相关死亡发生EOS(月)分别为46.9vs68.8vs53.1;p=0.48医大再次证实健择的疗效无法被超越!HdeyuYoshtomistal2013ASC0abstact4055JASPAC01:Randomizedphase山trialofadjuvantchemotherapywithgemcitabineversusS-1forpatientswithresectedpancreaticcancerAbstractNo:4008Presenter:AkiraFukutomi,MDE玟研究终点手术后10周分层因素E水s洁班2育2ss3国E-NON1aoL(Ea-5D)E8SA125125SBSA187)FREEEIISEXSXI33E05Epomommpmona葛en一、|s弘一cpogseen一月EFREEEIISY
